CIS Pharma

CIS Pharma is a private, Switzerland-based biotechnology company with a dual focus on ophthalmology and oncology. The company leverages its expertise in synthetic chemistry and biomaterials to create innovative drug delivery systems and therapeutic antibodies aimed at addressing significant unmet medical needs. Operating as a research and development innovator, CIS Pharma appears to be in a pre-revenue or early-revenue stage, advancing its pipeline through internal development and potential partnerships. Its strategic location in the European biotech hub provides access to scientific talent and collaborative networks.

Proprietary platform for synthesizing novel functional polymers and biomaterials to create advanced drug delivery systems and engineered antibodies for targeted, sustained release therapies.

In ophthalmology, competes with companies like Genentech (Roche), Regeneron, and emerging biotechs focused on sustained-release technologies. In oncology, faces competition from numerous ADC and targeted therapy developers, including large pharma and dedicated biotech firms.